HK1256344A1 - 製備氨基吡咯烷衍生物的方法 - Google Patents

製備氨基吡咯烷衍生物的方法

Info

Publication number
HK1256344A1
HK1256344A1 HK18115431.5A HK18115431A HK1256344A1 HK 1256344 A1 HK1256344 A1 HK 1256344A1 HK 18115431 A HK18115431 A HK 18115431A HK 1256344 A1 HK1256344 A1 HK 1256344A1
Authority
HK
Hong Kong
Prior art keywords
producing
aminopyrrolidine derivative
aminopyrrolidine
derivative
Prior art date
Application number
HK18115431.5A
Other languages
English (en)
Inventor
Hiroshi Miyazaki
Takao Komasaka
Joji Tsurumoto
Takeshi Uemura
Yuuji Morita
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1256344(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of HK1256344A1 publication Critical patent/HK1256344A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
HK18115431.5A 2013-09-05 2018-12-03 製備氨基吡咯烷衍生物的方法 HK1256344A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013073954 2013-09-05

Publications (1)

Publication Number Publication Date
HK1256344A1 true HK1256344A1 (zh) 2019-09-20

Family

ID=52628492

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16112135.3A HK1223928A1 (zh) 2013-09-05 2016-10-20 新型結晶性芳烷基胺化合物及其製造方法
HK18115431.5A HK1256344A1 (zh) 2013-09-05 2018-12-03 製備氨基吡咯烷衍生物的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16112135.3A HK1223928A1 (zh) 2013-09-05 2016-10-20 新型結晶性芳烷基胺化合物及其製造方法

Country Status (8)

Country Link
US (2) US9643920B2 (zh)
EP (2) EP3042893B1 (zh)
KR (6) KR20200093705A (zh)
CN (2) CN108484469A (zh)
ES (2) ES2795227T3 (zh)
HK (2) HK1223928A1 (zh)
TW (1) TWI637943B (zh)
WO (1) WO2015034031A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6168673B2 (ja) 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
WO2017061621A1 (ja) * 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
CN110167916B (zh) * 2017-01-13 2022-11-11 日产化学株式会社 芳香族二胺化合物前体的制造方法
JP2020105072A (ja) * 2017-03-24 2020-07-09 協和キリン株式会社 ポリエチレングリコール誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
CN1055090C (zh) * 1993-03-12 2000-08-02 法玛西雅厄普约翰美国公司 结晶性头孢噻夫游离酸
JPH0812670A (ja) 1994-04-26 1996-01-16 Kissei Pharmaceut Co Ltd 新規なピロリジン誘導体
AU2002331885B2 (en) * 2001-09-26 2007-07-26 Merck & Co., Inc. Crystalline forms of ertapenem sodium
JP4629036B2 (ja) * 2004-05-28 2011-02-09 田辺三菱製薬株式会社 アリールアルキルアミン化合物及びその製法
WO2009107579A1 (ja) 2008-02-25 2009-09-03 味の素株式会社 コク味付与剤
ES2420118T3 (es) 2008-12-09 2013-08-22 Interquim, S.A. Procedimiento para la preparación de (6S)-(-)-5,6,7,8-tetrahidro-6-[propil-(2-tienil)etil]amino-1-naftol (Rotigotina)
CA2762620A1 (en) * 2009-05-29 2010-12-02 Sumitomo Chemical Company, Limited Agent for treatment or prevention of diseases associated with activity of neurotrophic factors

Also Published As

Publication number Publication date
TW201546045A (zh) 2015-12-16
HK1223928A1 (zh) 2017-08-11
TWI637943B (zh) 2018-10-11
US10144708B2 (en) 2018-12-04
ES2699884T3 (es) 2019-02-13
EP3042893A4 (en) 2017-02-15
KR20170102375A (ko) 2017-09-08
KR20210119581A (ko) 2021-10-05
KR102460388B1 (ko) 2022-10-27
EP3042893A1 (en) 2016-07-13
KR20230159631A (ko) 2023-11-21
CN105517992A (zh) 2016-04-20
EP3360858A1 (en) 2018-08-15
CN105517992B (zh) 2018-06-22
KR20220150994A (ko) 2022-11-11
EP3360858B1 (en) 2020-04-29
US20170267633A1 (en) 2017-09-21
KR102177643B1 (ko) 2020-11-11
EP3042893B1 (en) 2018-10-31
WO2015034031A1 (ja) 2015-03-12
KR20160051833A (ko) 2016-05-11
KR20200093705A (ko) 2020-08-05
CN108484469A (zh) 2018-09-04
ES2795227T3 (es) 2020-11-23
KR102601941B1 (ko) 2023-11-15
US20160200679A1 (en) 2016-07-14
US9643920B2 (en) 2017-05-09

Similar Documents

Publication Publication Date Title
ZA201506401B (en) Process for producing hydrocarbons
PL3019577T3 (pl) Sposób wytwarzania węglowodorów
EP3042960A4 (en) Method for producing ambrein
SG11201505972SA (en) Process for producing polyols
EP2939978A4 (en) PROCESS FOR PRODUCING DIFLUOROPHOSPHATE
ZA201506725B (en) Method for producing leather
HK1256344A1 (zh) 製備氨基吡咯烷衍生物的方法
EP3061352A4 (en) Method for producing kakiage
SG11201600094YA (en) Method for producing polymer
SG11201504999TA (en) Method for producing polymer
EP2808376A4 (en) PROCESS FOR PRODUCING A COMPOSITION
SG11201601958WA (en) Method for producing butadiene
HUE037007T2 (hu) Eljárás pirrol származék elõállítására és annak intermediere
SG11201600061QA (en) Method for producing polymer
EP2998395A4 (en) METHOD FOR OBTAINING COMPOSITION CONTAINING LACTASE
PL2965172T3 (pl) Proces wykonania interfejsu audio-wizualnego
HK1218112A1 (zh) 多元醇的製造方法
IL241287A0 (en) Processes for the preparation of subfervir
LT3008198T (lt) Katino sintezės būdas
EP2999735A4 (en) PROCESS FOR PRODUCING A POLYMER
HK1220231A1 (zh) 細菌葉綠素 的生產方法
HK1215056A1 (zh) 用於製作納米本體的設備
HRP20181223T1 (hr) Proces proizvodnje fruktoze
EP2947049A4 (en) PROCESS FOR OBTAINING VET TYPE ZEOLITE
SG11201506828WA (en) Process for producing butadiene